Daiichi Presses On With Lead Pexidartinib Trial Despite Liver Toxicity

 
• By Ian Haydock
  
Liver anatomy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category